NCT03685188View on ClinicalTrials.gov

Oxycodone and Sufentanil for Analgesia in Hip Surgery

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

570

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

July 31, 2025

Conditions
Analgesia, Patient-Controlled
Interventions
DRUG

Oxycodone Hydrochloride

Subjects will receive patient' controlled intravenous analgesia in analgesic pump with 0.4 mg/ml of oxycodone for postoperative analgesia.

DRUG

Sufentanil Citrate

Subjects will receive patient' controlled intravenous analgesia in analgesic pump with 2 μg/ml of sufentanil for postoperative analgesia.

Trial Locations (1)

610041

West China Hospital, Sichuan University, Chengdu

All Listed Sponsors
lead

West China Hospital

OTHER